SK Plasma said on the 4th that it recently made the first shipment of plasma-derived fractionation products made from blood plasma donated by Indonesians from its Andong plant. Indonesia had previously imported all of its plasma-derived fractionation products.
The Indonesian Ministry of Social Affairs selected SK Plasma's local subsidiary, SK Plasma Core Indonesia, in 2023 as the operator for a project to localize plasma-derived fractionation products. Until local production infrastructure is in place, the company agreed to supply products using plasma donated by Indonesians through a CMO (contract manufacturing organization) model.
Indonesia sent plasma donated by its citizens to SK Plasma in April, and the Andong plant produced albumin and immunoglobulin through key processes. The company said it plans to contract-manufacture about 300,000 liters of plasma, starting with this export to Indonesia.